We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INVH icon
151
Invitation Homes
INVH
$17.6B
$23.3M 0.16%
785,067
+2,458
+0.3% +$77.9K
ASND icon
152
Ascendis Pharma A/S
ASND
$16.6B
$23.2M 0.16%
190,375
-16,000
-8% -$1.86M
CYTK icon
153
Cytokinetics
CYTK
$10.9B
$23.1M 0.16%
503,240
– –
BNTX icon
154
BioNTech
BNTX
$23B
$22.9M 0.15%
152,383
-63,033
-29% -$9.7M
NSC icon
155
Norfolk Southern
NSC
$77.1B
$22.8M 0.15%
92,549
+58,200
+169% +$13.8M
INTU icon
156
Intuit
INTU
$83.1B
$22M 0.15%
56,598
-12,644
-18% -$5.02M
MTD icon
157
Mettler-Toledo International
MTD
$27B
$21.9M 0.15%
15,183
+1,958
+15% +$2.62M
INTC icon
158
Intel
INTC
$462B
$21.9M 0.15%
828,348
+79,568
+11% +$2.21M
CLDX icon
159
Celldex Therapeutics
CLDX
$2.8B
$21.8M 0.15%
488,509
+70,000
+17% +$2.5M
FTV icon
160
Fortive
FTV
$19.2B
$21.2M 0.14%
437,235
+358,890
+458% +$17.4M
INSM icon
161
Insmed
INSM
$22.7B
$21M 0.14%
1,052,200
– –
TSM icon
162
TSMC
TSM
$2.07T
$21M 0.14%
281,696
-214,917
-43% -$15.5M
NWL icon
163
Newell Brands
NWL
$2.2B
$20.8M 0.14%
1,591,473
+265,732
+20% +$3.63M
KR icon
164
Kroger
KR
$35.5B
$20.7M 0.14%
463,907
+42,789
+10% +$1.97M
POWI icon
165
Power Integrations
POWI
$3.53B
$20.4M 0.14%
278,294
+2,399
+0.9% +$171K
HCA icon
166
HCA Healthcare
HCA
$86.4B
$20.2M 0.14%
84,115
-34,829
-29% -$7.8M
EW icon
167
Edwards Lifesciences
EW
$47.8B
$20.1M 0.14%
270,075
-220,201
-45% -$17M
EG icon
168
Everest Group
EG
$15.4B
$19.8M 0.13%
59,918
-13,443
-18% -$4.19M
ECL icon
169
Ecolab
ECL
$76.4B
$19.6M 0.13%
134,978
+21,866
+19% +$3.21M
BFAM icon
170
Bright Horizons
BFAM
$4.1B
$19.6M 0.13%
310,522
-16,604
-5% -$1.09M
PSA icon
171
Public Storage
PSA
$60.5B
$19.6M 0.13%
69,879
-2,188
-3% -$638K
AMBA icon
172
Ambarella
AMBA
$2.99B
$19.5M 0.13%
236,590
-241
-0.1% -$16K
TENB icon
173
Tenable Holdings
TENB
$3.58B
$19.4M 0.13%
509,808
+149,416
+41% +$5.48M
NFLX icon
174
Netflix
NFLX
$293B
$19.4M 0.13%
656,850
-71,060
-10% -$1.99M
VRNS icon
175
Varonis Systems
VRNS
$5.36B
$18.7M 0.13%
779,793
-163,064
-17% -$3.73M
5 6
7
8 9

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.